PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY
| Autor: | RRBN Presenter, N Shah, A Alencar, J Gerson, M Patel, W Jurczak, K Patel, A Mato, C Cheah, M Wang |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Hematology, Transfusion and Cell Therapy. 44:S127 |
| ISSN: | 2531-1379 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|